| __timestamp | Bausch Health Companies Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 2242216 |
| Thursday, January 1, 2015 | 582800000 | 4536244 |
| Friday, January 1, 2016 | 455000000 | 5184803 |
| Sunday, January 1, 2017 | 366000000 | 3068742 |
| Monday, January 1, 2018 | 414000000 | 7178000 |
| Tuesday, January 1, 2019 | 471000000 | 16267000 |
| Wednesday, January 1, 2020 | 452000000 | 23191000 |
| Friday, January 1, 2021 | 465000000 | 21453000 |
| Saturday, January 1, 2022 | 529000000 | 15265000 |
| Sunday, January 1, 2023 | 604000000 | 25189000 |
Unleashing insights
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Bausch Health Companies Inc. and Soleno Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
Bausch Health has consistently allocated substantial resources to R&D, with expenses peaking at approximately $604 million in 2023, marking a 145% increase from 2014. This robust investment underscores their dedication to advancing healthcare solutions. In contrast, Soleno Therapeutics, a smaller player, has shown a more modest yet steady increase in R&D spending, reaching around $25 million in 2023, a significant leap from $2.2 million in 2014.
These figures highlight the diverse strategies within the industry, where larger firms leverage their financial muscle, while smaller companies focus on niche innovations. The data reflects a dynamic sector poised for breakthroughs.
Eli Lilly and Company or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Comparing Innovation Spending: BioMarin Pharmaceutical Inc. and Soleno Therapeutics, Inc.
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Soleno Therapeutics, Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated